Transplantation for amyloidosis

Research output: Contribution to journalReview articlepeer-review

72 Scopus citations


PURPOSE OF REVIEW: High-dose chemotherapy increasingly is being used for the management of patients with immunoglobulin light-chain amyloidosis. We describe nearly 300 patients who had treatment combining high-dose chemotherapy and stem cell transplantation at Mayo Clinic and review the recent literature. RECENT FINDINGS: We review outcomes, engraftment data, and predictors of early mortality. The survival benefit of transplantation, however, has not been verified in a phase III clinical trial. SUMMARY: Partial response rates and complete response rates are prognosticators of survival for patients with amyloidosis. These rates are much higher for patients who receive high-dose therapy and transplantation.

Original languageEnglish (US)
Pages (from-to)136-141
Number of pages6
JournalCurrent Opinion in Oncology
Issue number2
StatePublished - Mar 2007


  • Amyloidosis
  • Multiple myeloma
  • Nephrotic syndrome
  • Restrictive cardiomyopathy
  • Stem cell transplantation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Transplantation for amyloidosis'. Together they form a unique fingerprint.

Cite this